Stay updated on Pembrolizumab for Meningioma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Meningioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Meningioma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page revision label was updated from v3.5.3 to v3.5.4, indicating an administrative update to the page template. No substantive content or study data were changed.
    Difference
    0.1%
    Check dated 2026-05-16T09:57:31.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page’s interface revision/version label was updated from v3.5.2 to v3.5.3 without changing the underlying study details shown on the record.
    Difference
    0.1%
    Check dated 2026-04-25T05:13:15.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-18T03:27:07.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Added site revision label v3.5.0 and removed the previous label v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T05:20:57.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T00:29:26.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    The page now shows a new site revision tag: Revision: v3.4.2, and the earlier funding-status notice and Revision: v3.4.1 tag have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T12:47:21.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Meningioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Meningioma Clinical Trial page.